The UC San Diego Medical Center, Hillcrest is one of two medical centers of UC San Diego Health and is a teaching hospital for the University of California San Diego School of Medicine.

During the past decade, University of California San Diego Medical Center - Hillcrest conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California San Diego Medical Center - Hillcrest" #1 sponsor was "University of California, San Diego" with 4 trials, followed by "Center for Medicinal Cannabis Research" with 2 trials sponsored, "Windtree Therapeutics" with 2 trials sponsored, "Pfizer" with 1 trials sponsored and "Puma Biotechnology, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California San Diego Medical Center - Hillcrest" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of California San Diego Medical Center - Hillcrest" are "Stroke" (2 trials), "Acute Alcoholic Hepatitis" (1 trials), "Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)" (1 trials), "Alcohol Abuse" (1 trials) and "Arterial Occlusive Disease" (1 trials). Many other conditions were trialed in "University of California San Diego Medical Center - Hillcrest" in a lesser frequency.

Most popular intervention types in "University of California San Diego Medical Center - Hillcrest" are "Drug" (8 trials), "Other" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aerosolized lucinactant" (1 trials), "Cannabis" (1 trials), "ELAD treatment" (1 trials), "Lower extremity Atherectomy and Cryoplasty" (1 trials) and "Lucinactant" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California San Diego Medical Center - Hillcrest" are 12 trials for "All" genders.

Currently, there are NaN active trials in "University of California San Diego Medical Center - Hillcrest". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in University of California San Diego Medical Center - Hillcrest, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of California San Diego Medical Center - Hillcrest, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".